Pagbabakuna kontra COVID-19 sa Pilipinas

Mula sa Wikipedia, ang malayang ensiklopedya
Jump to navigation Jump to search
Pagbabakuna kontra COVID-19 sa Pilipinas
Resbakuna logo.png
Petsa1 Marso 2021 (2021-03-01) – kasalukuyan
LugarPilipinas
DahilanPandemya ng COVID-19 sa Pilipinas
Organized byKagawaran ng Kalusugan (DOH)
Mga sangkot51,985,108 na dosis ang naipamahagi[1][a]
Kinalabasan25.51% ng populasyon ang nakatanggap ng kahit isang dosis ng bakuna
22.17% ang tapos nang bakunahan

Ang pagbabakuna kontra COVID-19 sa Pilipinas ay isang programang Resbakuna, upang mabakunahan ang mga mamamayan kontra severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), ang virus na nagdudulot ng coronavirus disease 2019 (COVID-19), bilang tugon sa kasalukuyang pandemya sa bansa.

The Food and Drug Administration (FDA) has issued "emergency use authorization"s (EUA) to 8 COVID-19 vaccines (in chronological order): Pfizer–BioNTech, Oxford–AstraZeneca, CoronaVac, Sputnik V, Janssen, Covaxin, Moderna, at Sinopharm. There are eight other vaccines on order for the program, at varying stages of development.

As of Oktubre 22, 2021, about 8,591,406 total vaccine doses have been administered throughout the country. 6,407,917 individuals have been vaccinated across the country, with 2,183,489 receiving the second dose.[1][2][3]

Tingnan ang[baguhin | baguhin ang batayan]

Talababa[baguhin | baguhin ang batayan]

  1. 6,407,917 sa mga ito ay unang dosis pa lamang ang natatanggap, habang 2,183,489 naman ang tapos nang bakunahan.

Talasanggunian[baguhin | baguhin ang batayan]

  1. 1.0 1.1 "Vaccine Statistics: As of June 21, 2021". Department of Health. Nakuha noong June 23, 2021.
  2. "TRACKER: The Philippines' COVID-19 vaccine distribution". Rappler. April 1, 2021. Nakuha noong April 15, 2021.
  3. "Philippines: COVID-19 Vaccine Tracker". ABS-CBN News. ABS-CBN Corporation. March 23, 2021. Nakuha noong April 14, 2021.